Edesa Biotech, Inc. (EDSA)
$2.94-16.24%Close
SELLCRISIS · day 37
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $28M
- Beta
- 1.06
- P/E (TTM)
- -2.20
- Short % float
- 2.65%
- Days to cover
- 4.8
- SI change
- -7.0%
- 1W
- -24.81%
- 1M
- -30.50%
- vs SPY 1W
- -25.23%
- vs SPY 1M
- -32.56%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on EDSA?
- LOPJLB’s latest quantitative signal on Edesa Biotech, Inc. (EDSA) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is EDSA in?
- Edesa Biotech, Inc. (EDSA) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Edesa Biotech, Inc. (EDSA) do?
- Edesa Biotech, Inc. is a biopharmaceutical firm focused on discovering, developing, and commercializing clinical-stage treatments for inflammatory and immune system disorders where current medical options are inadequate. The company's key pipeline assets include EB05, a monoclonal antibody undergoing a Phase 3 clinical trial for acute respiratory distress syndrome (ARDS) in COVID-19 patients, a…